MedTrace Logo

The Impact of a Heart Failure Review on Self-Care Knowledge, Adherence and Clinical Outcomes

NCT02415751 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2019-01-30

No results posted yet for this study

Summary

This study is assessing the effects of a new heart failure self-care education program in the Nebraska Heart Institute Heart Improvement Clinic. The new education program will consist of an initial intensive self-care education session with the Principal Investigator or her nurse practitioner. Topics to be discussed include medications, sodium and fluid consumption, alcohol restriction, exercise, preventive behaviors, and monitoring of signs and symptoms. As recommended in the ACCF/AHA guidelines, this education will be repeated on an annual basis as studies have shown that the impact of HF education is not always durable and must be a continual process. This study will assess the impact of this review on their medication knowledge, disease state knowledge, quality of life, disease state progression and clinical outcomes such as ejection fraction and number of hospitalizations.

Conditions

Interventions

BEHAVIORAL

heart failure self-care education

It is defined as a naturalistic decision-making process that patients use in the choice of behaviors that maintain physiological stability (symptom monitoring and treatment adherence) and the response to symptoms when they occur (Riegel 2004). This includes following advice regarding medications, sodium and water consumption, alcohol restriction, exercise, preventive behaviors, and monitoring of signs and symptoms.

Sponsors & Collaborators

  • CHI Nebraska Heart

    collaborator UNKNOWN

  • Creighton University

    lead OTHER

Principal Investigators

  • Katie Packard, PharmD · Creighton University

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2019-01-22
Completion
2019-01-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02415751 on ClinicalTrials.gov